In policy meetings and committee rooms across the country, newborn screening conditions are regularly scored, debated, and weighed. Leaders evaluate analytical validity, treatment efficacy, and system capacity. But every so...
The Strongest Advocacy Partnerships Begin Before There Is a Project Many biopharma companies first engage patient advocacy organizations when a specific need arises. A clinical trial needs recruitment support. A...
Trust Is Built Long Before It Is Needed Trust is often described as a cornerstone of healthcare. In patient advocacy and biopharma partnerships, it is something even more fundamental. It...
The Strongest Advocacy Partnerships Are Built on Trust, Not Funding Many sponsors recognize the importance of working with patient advocacy organizations. Yet too often, these relationships begin and end with...
The Best Partnerships Create Value for Everyone Involved The strongest patient advocacy partnerships are not built around what one organization needs from another. They are built around what both organizations...
